Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.48 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.43 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.43 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.43 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5022360 | 0.97 | LMNA (0.50) | LMNASLC22A6TSHRNFKB1APEX1 | |
| Ammonia Solution, Strong SCHEMBL4613756 | 0.97 | LMNA (0.50) | LMNASLC22A6TSHRNFKB1APEX1 | |
| SCHEMBL2524491 | 0.97 | LMNA (0.50) | LMNASLC22A6TSHRNFKB1APEX1 | |
| SCHEMBL2516913 | 0.97 | LMNA (0.50) | LMNASLC22A6TSHRNFKB1APEX1 | |
| SCHEMBL2526703 | 0.97 | LMNA (0.50) | LMNASLC22A6TSHRNFKB1APEX1 | |
| SCHEMBL513681 | 0.92 | LMNA (0.58) | LMNASLC22A6TSHRNFKB1APEX1 | |
| SCHEMBL503550 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL8576746 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL7609467 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 | |
| SCHEMBL8574509 | 0.90 | TSHR (0.60) | LMNASLC22A6TSHRNFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117659908-A | Preparation method and application of high-molecular polymer water-based binder | 东方醒狮储能电池有限公司 | 2024-03-08 | — | — | CN | claimed |
| US-10947123-B2 | Synthetic caustic composition | FLUID ENERGY GROUP LTD. (CA) | 2021-03-16 | — | — | US | claimed |
| CN-105848617-B | Wound care article | BSN医疗有限公司 | 2020-03-20 | — | — | CN | claimed |
| US-20190144741-A1 | NOVEL SYNTHETIC CAUSTIC COMPOSITION | HSBC BANK MIDDLE EAST LIMITED (AE) | 2019-05-16 | — | — | US | claimed |
| EP-1169405-B1 | QUATERNARY NITROGEN CONTAINING AMPHOTERIC WATER SOLUBLE POLYMERS AND THEIR USE IN DRILLING FLUIDS | AKZO NOBEL NV (NL) | 2008-02-27 | — | — | EP | claimed |
| US-7335686-B2 | Method and composition for treating osteoporosis | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2008-02-26 | — | — | US | claimed |
| EP-1680396-A1 | NOVEL MOLECULE FOR INDUCING DIFFERENTIATION OF DENDRITIC CELLS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-07-19 | — | — | EP | claimed |
| EP-1678124-A1 | NOVEL MOLECULES TO DEVELOP DRUG FOR THE TREATMENT OF OSTEOPOROSIS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2006-07-12 | — | — | EP | claimed |
| EP-1678125-A1 | NOVEL MOLECULE FOR INDUCING DIFFERENTIATION OF DENDRITIC CELLS | Council of Scientific and Industrial Research (IN) | 2006-07-12 | — | — | EP | claimed |
| WO-2005037774-A1 | NOVEL MOLECULES TO DEVELOP DRUG FOR THE TREATMENT OF OSTEOPOROSIS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2005-04-28 | — | — | WO | claimed |
| US-20050085546-A1 | Method of inducing differentiation of dendritic cells | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2005-04-21 | — | — | US | claimed |
| CN-1125844-C | New protective colloids in latices with improved film formation at low temp | HERCULES INC (US) | 2003-10-29 | — | — | CN | claimed |
| EP-1169405-A2 | QUATERNARY NITROGEN CONTAINING AMPHOTERIC WATER SOLUBLE POLYMERS AND THEIR USE IN DRILLING FLUIDS | Akzo Nobel N.V. (NL) | 2002-01-09 | — | — | EP | claimed |
| US-6281172-B1 | RHEOLOGICAL CONTROL AGENT | AKZO NOBEL NV (NL) | 2001-08-28 | — | — | US | claimed |
| CN-1305506-A | New protective colloids in latices with improved film formation at low temp | HERCULES INC (US) | 2001-07-25 | — | — | CN | claimed |
| WO-2000060023-A2 | QUATERNARY NITROGEN CONTAINING AMPHOTERIC WATER SOLUBLE POLYMERS AND THEIR USE IN DRILLING FLUIDS | AKZO NOBEL N.V. (NL) | 2000-10-12 | — | — | WO | claimed |
| EP-0613482-B1 | METHOD OF PREPARING ALKYL AND/OR ALKENYL OLIGOGLYCOSIDES | HENKEL KGAA (DE) | 1997-06-04 | — | — | EP | claimed |
| US-5480979-A | REACTING GLYCOSE WITH FATTY ALCOHOL IN PRESENCE OF ACID CATALYST, I.E., SULFOMONOCARBOXYLIC ACID, ANHYDRIDE OF SULFOMONOCARBOXYLIC ACID AND/OR MIXED CYCLIC SULFONIC ACID CARBOXYLIC ACID ANHYDRIDE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1996-01-02 | — | — | US | claimed |
| US-5324777-A | Process for the production of polymers containing ammonium groups | WOLFF WALSRODE AG (DE) | 1994-06-28 | — | — | US | claimed |
| EP-0410883-A2 | Di-lysogangliosides derivatives | FIDIA S.p.A. (IT) | 1991-01-30 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050085546-A1 | Method of inducing differentiation of dendritic cells | MSR1, MYD88, CD14 | LMNA 3969/4885SLC22A6 332/4885TSHR 696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.